VenomTech company announces massive library of SNAKE VENOM peptides for pharmaceutical development; “nanocarriers” stabilize snake venom in WATER (PubMed)

Earlier today, a UK company literally named “Venomtech” announced a massive venom peptide and venom fragment library to be used for drug discovery by pharmaceutical companies (as well as pesticide used for agricultural companies).

Venomtech is collaborating with Charles River Laboratories, International Inc. to help drug developers explore venom-derived compounds for a wide range of therapeutic targets. This newly formed collaboration will bring together Venomtech’s biology expertise and vast venom-derived peptide library, with Charles River’s drug development and screening knowhow, providing pharmaceutical manufacturers with a one-stop service to explore this unique natural resource.

Venomtech’s Targeted-Venom Discovery Array™ (T-VDA™) libraries provide researchers with a straightforward solution to rapidly screen thousands of individual venom fragments, with each array specifically designed to maximise hits for a specific target.

VenomTech company announces massive library of SNAKE VENOM peptides for pharmaceutical development; “nanocarriers” stabilize snake venom in WATER (PubMed) – NaturalNews.com